China Medicine Corporation (CHME)

[funnyG986]

CHME DD INFO; 0.0105 X 0.013 NEXT CH*G


CHME DD - very quiet buying happening. One to keep an eye on:

O/S only 27 mil.

http://www.cmc621.com/about/index.php?id=1

OEP is the major holder for CHME, which is the branch of JPMorgan Chase

CHME company found on OEP website.
www.oneequity.com/AllCompanies

CHME shows One Equity Partners (OEP) owns 42.7% of the company.

Major Direct Holders (Forms 3 & 4)
OEP CHME HOLDINGS, LLC 8,333,334 Dec 30, 2010
www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8826929

OEP CHME Holdings, LLC operates as a subsidiary of OEP Parent LLC.
http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=256554989

One Equity Partners (OEP) makes private equity investments behind compelling business ideas and strong management teams. Since inception in 2001, OEP has managed approximately $14 billion in total investments and committed capital for JPMorgan Chase & Co., and OEP has delivered strong returns throughout this thirteen year period.
http://www.oneequity.com/About_1


CHME company is alive! company news link shows

Development of Overseas Market—Technical Service in Pakistan9 Dec 2014

In order to further expand overseas markets, our company sent technical staff to our exclusive agent Ghazi Brothers in Pakistan for technical services. As the largest distributor in Pakistan, Ghazi Brothers started the sale of our product Feed additive-Aflatoxin B1-detoxinfizyme in 2012. Due to the increasing customer number and growing market demand, our company accepted Ghazi Brothers’ invitation and went to Pakistan with the purpose of helping them exploit the new market.

http://www.uskonzern.com/content.php?lid=7

Who We Are
We are a leading pharmaceutical and nutraceutical group in China, specialized in dietary supplement, medicine, and biotech projects. Invested by China Medicine Cooperation, USA (NASQ Symbol: CHME.OB)., Konzern Group Limited was established in 2010 based on Guangzhou Konzern Medicine Co., Ltd., which has more than ten years of history in medicine and nutraceutical selling in China.
Now we have a R&D Centre with cutting-edge technology, which makes us the carrier of 863 Program (National High-tech R&D Program of China) and Guangdong Important Science and Technology Project.